VCU Center for Drug Discovery

News

Qingguo Xu, D.Phil., associate professor of pharmaceutics and ophthalmology at VCU School of Pharmacy, (right) in the lab with Tuo Meng, Ph.D., (left) and Vineet Kulkarni. (School of Pharmacy)

Tiny nanoparticle could have big impact on patients receiving corneal transplants

March 23, 2023

In VCU-led studies, using nanoparticles to encapsulate eye medication decreased graft rejection while requiring fewer and smaller doses.

Qingguo Xu, Ph.D., an associate professor in the Department of Pharmaceutics of the School of Pharmacy, was one of six recipients of the fall 2022 round of TechTransfer and Ventures’ Commercialization Fund Awards. (Tom Kojcsich, Enterprise Marketing and Communications)

Drug delivery, new therapies, AI, VR: Array of VCU inventors receive Commercialization Fund awards

Feb. 28, 2023

Cholesterol drug may help treat eye disorders.

Congratulations to Akua K. Donkor

Feb. 27, 2023

Donkor has been offered a co-op position at Merck Research Lab.